论文部分内容阅读
目的:观察分析祛风活血汤用于白内障患者术后虹膜睫状体炎治疗的方式与效果。方法:选取我院2012年6月~2015年9月收治的80例白内障术后虹膜睫状体炎患者,随机平均分为治疗组与对照组,对照组予以常规西医治疗,治疗组加用祛风活血汤,对比2组综合疗效及治愈时间。结果:对照组治疗后治愈14例,好转19例,无效7例,总有效率82.5%;治疗组治愈28例,好转9例,无效3例,总有效率92.5%,显著高于对照组(P<0.05)。对照组治愈时间≤3d共3例、11例为4~7天、12例为8~11天、7例为12~15天、8例>15天,平均治愈时间(10.9±4.3)天;治疗组治愈时间≤3天共5例、15例为4~7天、13例为8~11天、4例为12~15天、3例>15天,平均治愈时间(7.4±1.2)天,治愈时间短于对照组(P<0.05)。结论:西医治疗基础上联合祛风活血汤有助于缩短白内障术后虹膜睫状体患者治愈期,还能提升综合疗效,值得将此种中西医联合治疗方式推荐作为白内障术后虹膜睫状体炎的首选疗法。
Objective: To observe and analyze the method and effect of Qufeng Huoxue Decoction for the treatment of postoperative iridocyclitis in cataract patients. Methods: Eighty patients with iridocyclitis who underwent cataract surgery in our hospital from June 2012 to September 2015 were randomly divided into treatment group and control group. The control group was treated with conventional western medicine, and the treatment group was treated with cured Wind and Blood Decoction, compared with two groups of comprehensive treatment and cure time. Results: In the control group, 14 cases were cured, 19 cases were improved, 7 cases were ineffective, and the total effective rate was 82.5%. In the treatment group, 28 cases were cured, 9 cases were improved, 3 cases were ineffective, the total effective rate was 92.5%, significantly higher than that of the control group P <0.05). In the control group, 3 cases were cured within 3 days, 11 cases were 4 to 7 days, 12 cases were 8 to 11 days, 7 cases were 12 to 15 days, 8 cases were> 15 days and the average healing time was 10.9 ± 4.3 days. In the treatment group, 5 cases were cured within 3 days, 15 cases were 4 to 7 days, 13 cases were 8 to 11 days, 4 cases were 12 to 15 days, 3 cases were> 15 days and the average healing time was 7.4 ± 1.2 days , The cure time is shorter than the control group (P <0.05). Conclusion: Western medicine combined with Qufeng Huoxue Decoction can help to shorten the cure of cataract patients after iridocyclitis, but also enhance the comprehensive effect, it is worth the combination of Chinese and Western medicine recommended as cataract surgery iridocyclitis Inflammation of the preferred therapy.